ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,561.53
0.56%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.275
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Tourmaline Bio Inc (TRML)

  7. Tourmaline Bio Inc (TRML) ニュース

TRML Tourmaline Bio Inc

16.96
0.36 (2.17%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Tourmaline Bio Inc TRML NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.36 2.17% 16.96 06:16:11
始値 安値 高値 終値 前日終値
16.64 16.44 17.19 16.96 16.60
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0805:04EDGAR2Form 8-K - Current report
2024/6/0805:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0805:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2320:10GLOBETourmaline Bio to Present at the Jefferies Global Healthcare..
2024/5/1620:00GLOBETourmaline Bio Initiates Clinical Development of TOUR006 for..
2024/5/1405:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1320:15EDGAR2Form 8-K - Current report
2024/5/1320:00GLOBETourmaline Bio Reports First Quarter 2024 Financial Results..
2024/4/0220:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
2024/3/1920:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
2024/2/2721:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
2024/2/1511:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1510:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1006:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0122:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
2024/1/3006:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
2024/1/2706:12EDGAR2Form 8-K - Current report
2024/1/2706:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/2521:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
2024/1/2511:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/2507:10EDGAR2Form 8-K - Current report
2024/1/2506:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
2024/1/0823:19EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
2023/12/1606:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
2023/12/1422:27EDGAR2Form 8-K - Current report
2023/12/1421:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
2023/11/3022:25EDGAR2Form 8-K - Current report
2023/11/0121:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
2023/10/2409:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2409:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2407:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/2006:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..

最近閲覧した銘柄

NASDAQ
TRML
Tourmaline Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有